Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q1 EPS of ($0.33), $0.04 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.